Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-21

Clinical Trial Update: A Study of Abemaciclib in Indian Women With Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update of abemaciclib in Indian women with advanced breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abemaciclib (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms, Neoplasm Metastasis | Phase 4 | Status: COMPLETED | Results posted: 2023-11-21